KEYNOTE-029: Alternate Doses of Ipilimumab Show Similar Results in Advanced Melanoma

Researchers tested standard-dose pembrolizumab plus ipilimumab at 50-mg or 100-mg doses in patients with previously untreated advanced melanoma.

Source: CancerNetwork - June 4, 2019 Category: Cancer & Oncology Authors: Lauren M. Dembeck Source Type: news